Pharming Group N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 21 oct 2020 - 07:07
- Statutory name Pharming Group N.V.
- Title Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
|202010210000000002_38135091-PR Leniolisib ODD 20OCT2020 final.docx|
Date last update: 02 December 2020